FDA approves mpox vaccine requiring 15 'vigorous' jabs

Emergent BioSolutions’ smallpox vaccine is now FDA-approved for the prevention of mpox, the drugmaker said Aug. 29. 

Read the full post on Becker's Hospital Review | Healthcare News & Analysis